Gene therapy offers new hope for genetic diseases but not everyone can receive it. Explore who qualifies and why eligibility matters.

ELIGIBILITY QUESTIONS

WHAT IS GENE THERAPY? 

WHAT IS GENE THERAPY?

Gene therapy replaces or repairs faulty genes to treat diseases at their source.

HOW DOES IT WORK?

Using viral vectors, healthy genes are delivered into patient cells to restore normal function.

WHO IS ELIGIBLE?

Not every patient can undergo gene therapy. Severe comorbidities or organ failure may prevent it.

IMMUNE SYSTEM MATTERS

Autoimmune disorders or previous immune reactions can reduce gene therapy’s success.

ACCESS AND BARRIERS

Geography and infrastructure limit access rural areas often lack gene therapy centers.

COST AND PRODUCTION CHALLENGES

High costs and limited manufacturing slow down global availability of gene therapy.

FUTURE OF GENE THERAPY

New technologies like CRISPR and better vectors promise safer, wider access in the near future.

Stories

More

HEMATOLOGY: 5 KEY WAYS CHEMO IMPACTS BLOOD DISORDERS

GENE THERAPY: CHANGING THE FUTURE OF CANCER CARE